[Clinical studies on activators and inhibitors of fibrinolysis in various internal diseases].
D000614:Aminocaproates / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D002908:Chronic Disease; D005260:Female; D005341:Fibrinolysin / Q000627:therapeutic use; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D009205:Myocarditis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D000970:Antineoplastic Agents; D005343:Fibrinolytic Agents; D006493:Heparin; D005341:Fibrinolysin
Klinische Untersuchungen über Aktivatoren und Inhibitoren der Fibrinolyse bei einigen inneren Krankheiten